参考文献/References:
[1]WANG Wei, ZHOU Wei, WU Shao-wei, et al. Perfluoroalkyl substances exposure and risk of polycystic ovarian syndrome related infertility in Chinese women [J]. Environmental Pollution, 2019, 247(1): 824-831.
[2]Starling AP, Adgate JL, Hamman RF, et al. Perfluoroalkyl substances during pregnancy and offspring weight and adiposity at birth: examining mediation by maternal fasting glucose in the healthy start study[J]. Environ Health Perspect, 2017, 125(6): 067016.
[3]Halldorsson TI, Rytter D, Haug LS, et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study [J]. Environ Health Perspect, 2012, 120(5): 668-673.
[4]Bossi R, Riget FF, Dietz R, et al. Preliminary screening of perfluorooctane sulfonate(PFOS)and other fluorochemicals in fish,birds and marine mammals from Greenland and the Faroe Islands[J]. Environmental Pollution, 2005, 136(2): 323-329.
[5]Seacat AM, Thomford PJ, Hansen KJ, et al. Subchronic toxicity studies on perfluorooctane sulfonate potassium salt in cynomolgus monkeys [J]. Toxicol Sci, 2002, 68(1): 249-264.
[6]Buhrke T, Krüger, Eileen, Pevny S, et al. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes [J]. Toxicology, 2015, 333:53-62.
[7]GAO Yu, LI Xin-xin, GUO Liang-hong. Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor[J]. Environ Sci Technol, 2013, 47(1): 634-641.
[8]Albrecht PP, Torsell NE, Krishnan PA, et al. A species difference in the peroxisome proliferator-activated receptor-dependent response to the developmental effects of perfluorooctanoic acid [J]. Toxicological Sciences, 2013, 131(2): 568-582.
[9]Bonefeld-Jorgensen EC, LONG Man-hai, Bossi RA, et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: A case control study [J]. Environmental Health, 2011, 10(1): 88.
[10]Dominguez A, Salazar Z, Arenas E, et al. Effect of perHuorooctane sulfonate on viability, maturation and gap functional intercellular communication of porcine oocytes in vibo [J]. Toxicol In Vitro, 2016, 35:93-99.
[11]Governini L, Orvieto R, Guerranti CA, et al. The impact of environmental exposure to perfluorinated compounds on oocyte fertilization capacity [J]. J Assist Reprod Genet, 2011, 28(5): 415-418.
[12]Petro EM, D'hollander W, Covaci A, et al. Perfluoroalkyl acid contamination of follicular fluid and its consequence for in vitro oocyte developmental competence [J]. Sci Total Environ, 2014, 496(7): 282-288.
[13]Sakr CJ, Hreclanann H, Green JW, et al. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure ammonium perfluorooctanoate or APFO as part of a general health survey in a cohort of occupationally exposed workers [J]. J Occup Environ Med, 2007, 49(10): 1086-1096.
[14]Barrett ES, CHEN C, Thurston S, et al. PerHuoroalkyl substances and ovarian hormone concentrations in naturally cycling women[J]. Fertil Steril, 2015, 103(5): 1261-1270.
[15]ZhouW, ZHANG L, TONG C, et al. Shanghai birth cohort study.plasmaperfluoroalkyl and polyfluoroalkyl substances concentration and menstrual cycle characteristics in preconception women [J]. Environ Health Perspect, 2017, 125(6): 067012.
[16]Bach C C, Vested A, JRgensen K T, et al. Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review[J]. Critical Reviews in Toxicology, 2016:1-21.
[17]Escobar-Morreale, Héctor F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment [J]. Nature Reviews Endocrinology, 2018,14, 270 e 284.
[18]Palioura E, Diamanti-Kandarakis E . Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)[J]. Reviews in Endocrine and Metabolic Disorders, 2015, 16(4):365-371.
[19]Vagi S J, Azziz-Baumgartner E, Sj Din A, et al. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case-control study[J]. BMC Endocrine Disorders, 2014, 14(1):86.
[20]Li L, Zhai Z, Liu J, et al. Estimating industrial and domestic environmental releases of perflfluorooctanoic acid and its salts in China from 2004 to 2012 [J].Chemosphere,2015,129: 100 e 109.
[21]Macer, L M, Taylor, et al. Endometriosis and infertility:a review of the pathogenesisand treatment of endometriosis-associated infertility [J]. Obstet Gynecol Clin,2012,39(4): 535-549.
[22]Henry, D N, Fair, et al. Comparison of in vitro,cytotoxicity,estrogenicity and antiestrogenicity of triclosan,perflfluorooctane sulfonate and perflfluorooctanoic acid [J]. J Appl Toxicol,2013,33(4): 265-272.
[23]Guizhen DO, Hu YZJ, HUANG YZH, et al. Perflfluorooctane sulfonate(PFOS)affects hormone receptor activity,steroidogenesis,and expression of endocrine-related genes in vitro and in vivo[J]. Environ Toxicol Chem,2013,32(2): 353-360.
[24]Campbell S, Raza M, Pollack A Z . Perfluoroalkyl substances and endometriosis in US women in NHANES 2003–2006[J]. Reproductive Toxicology, 2016, 65:230-235.
[25]Feng X, Cao X, Zhao S, et al. Exposure of pregnant mice to perfluorobutanesulfonate causes hypothyroxinemia and developmental abnormalities in female offspring [J]. Toxicological Sciences, 2016:kfw 219.
[26]Apelberg BJ, Witter FR, Herbstman JB, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth[J]. Environ Health Perspect, 2007, 115(11): 1670-1676.
[27]FEI Chun-yuan, Mclaughlin JK, Tarone RE, et al. Fetal growth indicators and perfluorinated chemicals: A study in the Danish National Birth Cohort [J]. Am J Epidemiol, 2008, 168(1): 66-72.
[28]Kishi R, Nakajima T, Goudarzi H, et al. The association of prenatal exposure to perfluorinated chemicals with maternal essential and long-chain polyunsaturated fatty acids during pregnancy and the birth weight of their offspring: the Hokkaido study[J]. Environ Health Perspect, 2015, 123(10): 1038-1045.
[29]Maisonet M. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls[J]. Environ Health Perspect, 2012, 120(10): 1432–1437.
[30]Chen MH, Ng S, Hsieh CJ, et al. The impact of prenatal perfluoroalkyl substances exposure on neonatal and child growth [J]. Sci Total Environ, 2017, 607(6): 669-675.
[31]Mogensen UB, Grandjean P, Heilmann CA, et al. Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates[J]. Environmental Health, 2015, 14(1): 47.
[32]Grandjean P, Heilmann C, Weihe P, et al. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years [J]. J Immunotoxicol, 2017, 14(1): 188-195.
[33]Granum B, Haug LS, Namork E, et al. Pre-natal exposure to perfluoroalkyl substances May be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood[J]. J Immunotoxicol, 2013, 10(4): 373-379.
[34]Dalsager L, Christensen N, Husby S, et al. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4 years among 359 children in the Odense Child Cohort [J]. Environ Int, 2016, 96(8): 58-64.
[35]Okada E, Sasaki S, Saijo Y, et al. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants [J]. Environ Res, 2012, 112(10): 118-125.
[36]Wang IJ, Hsieh WS, Chen CY, et al. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy [J]. Environ Res, 2011, 111(6): 785-791.
[37]Buser MC, Scinicariello F. Perfluoroalkyl substances and food allergies in adolescents [J]. Environ Int, 2016, 88(2): 74-79.
[38]DONG Guang-hui, Tung KY, Tsai CH, et al. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a Case-Control study of taiwanese children[J]. Environ Health Perspect, 2013, 121(4): 507-513.
[39]ZHU Yu, QIN Xiao-di, ZENG Xiao-wen, et al. Associations of serum perfluoroalkyl acid levels with T-helper cell-specific cytokines in children: By gender and asthma status [J]. Sci Total Environ, 2016, 559(3): 166-173.
[40]Oulhote Y, Shamim Z, Kielsen K, et al. Children's white blood cell counts in relation to developmental exposures to methylmercury and persistent organic pollutants[J]. Reproductive Toxicology, 2017, 68(SI): 207-214.
[41]Goudarzi H, Nakajima S, Ikeno T, et al. Prenatal exposure to perfluorinated chemicals and neurodevelopment in early infancy: The Hokkaido Study[J]. Sci Total Environ, 2016, 541(10): 1002-1010.
[42]Donauer S, CHEN Ai-min, XU Ying-ying, et al. Prenatal exposure to polybrominated diphenyl ethers and polyfluoroalkyl chemicals and infant neurobehavior[J]. Journal of Pediatrics, 2015, 166(3): 736-742.
[43]Stein CR, Savitz DA. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age [J]. Environ Health Perspect, 2011, 119(10): 1466-1471.
[44]Gump BB, WU Qian, Dumas AK, et al. Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition[J]. Environ Sci Technol, 2011, 45(19): 8151-8159.
[45]Liew Z, Ritz B, Von Ehrenstein OS, et al. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested Case-Control study in the Danish National birth cohort[J]. Environ Health Perspect, 2015, 123(4): 367-373.
[46]Ode A, Kallen K, Gustafsson P, et al. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood [J]. PLoS One, 2014, 9(4): e 95891.
[47]Strom M, Hansen S, Olsen SF, et al. Persistent organic pollutants measured in maternal serum and offspring neurodevelopmental outcomes - A prospective study with long-term follow-up [J]. Environ Int, 2014, 68(3): 41-48.
[48]Quaak I, De Cock M, De Boer M, et al. Prenatal exposure to perfluoroalkyl substances and behavioral development in children[J]. Int J Environ Res Public Health, 2016, 13(5): 10.
[49]Oulhote Y, Steuerwald U, Debes F, et al. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances[J]. Environ Int, 2016, 97(9): 237-245.
[50]Lien GW, Huang CC, Shiu JS, et al. Perfluoroalkyl substances in cord blood and attention deficit/hyperactivity disorder symptoms in seven-year-old children[J]. Chemosphere, 2016, 156(4): 118-127.
[51]FEI C. Perfluorinated chemicals and fetal growth:a study within the Danish National birth cohort[J]. Environ Health Perspect, 2007, 115(11): 1677–1682.
[52]Rappazzo KM, Coffman E, Hines EP. Exposure to perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature [J]. Int J Environ Res Public Health, 2017, 14(7): 691.
[53]Winkens K. Early life exposure to per-and polyfluoroalkyl substances(PFASs):a critical review [J]. Emerg Contam, 2017, 3(2): 55–68.
[54]Sagiv SK, Rifas-Shiman SL, Webster TF, et al. Sociodemographic and perinatal predictors of early pregnancy Per- and polyfluoroalkyl substance (PFAS) concentrations [J]. Environ Sci Technol, 2015, 49(19): 11849-11858.
[55]Harris MH, Rifas-Shiman SL, Calafat AM, et al. Predictors of Per- and polyfluoroalkyl substance (PFAS) plasma concentrations in 6-10 year old American children [J]. Environ Sci Technol, 2017, 51(9): 5193-5204.
[56]Xindi C. Hu,David Q. Andrews,Andrew B. Lindstrom,et al.Detection of Poly- and Perfluoroalkyl Substances (PFASs) in U.S.Drinking water linked to industrial sites, military fire training areas,and wastewater treatment plants [J]. Environ Sci Technol Lett, 2016,3(10):344-350.
[57]Grandjean P, Heilmann C, Weihe P, et al.Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds [J].Environ Health Perspect,2017, 125(7):077018.